Your browser doesn't support javascript.
loading
Arginine kinetics are altered in a pilot sample of adolescents and young adults with Barth syndrome.
Cade, W Todd; Bohnert, Kathryn L; Bittel, Adam J; Chacko, Shaji J; Patterson, Bruce W; Pacak, Christina A; Byrne, Barry J; Vernon, Hilary J; Reeds, Dominic N.
Affiliation
  • Cade WT; Program in Physical Therapy, Washington University School of Medicine, St. Louis, MO, United States.
  • Bohnert KL; Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
  • Bittel AJ; Doctor of Physical Therapy Division, Duke University School of Medicine, Durham, NC, United States.
  • Chacko SJ; Program in Physical Therapy, Washington University School of Medicine, St. Louis, MO, United States.
  • Patterson BW; Program in Physical Therapy, Washington University School of Medicine, St. Louis, MO, United States.
  • Pacak CA; Department of Pediatrics, Children's Nutrition Research Center, U.S. Department of Agriculture/Agricultural Research Service, Baylor College of Medicine, Houston, TX, United States.
  • Byrne BJ; Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
  • Vernon HJ; Department of Pediatrics, University of Florida School of Medicine, Gainesville, FL, United States.
  • Reeds DN; Department of Pediatrics, University of Florida School of Medicine, Gainesville, FL, United States.
Mol Genet Metab Rep ; 25: 100675, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33204638
ABSTRACT
Barth syndrome (BTHS) is a rare, X-linked cardiomyopathy that is characterized by abnormalities in glucose and lipid metabolism, with less known regarding amino acid metabolism. This pilot study characterized whole-body arginine kinetics and found lower arginine rate of appearance into plasma (0.69 ± 0.09 vs. 0.88 ± 0.06 µmol/kgFFM/min, p < 0.01) and arginine non-oxidative disposal rate (0.64 ± 0.11 vs. 0.80 ± 0.03 µmol/kgFFM/min, p < 0.02) in adolescents and young adults with BTHS compared to Controls. This study provides a foundation for more in-depth studies on how arginine and potentially other amino acid abnormalities contribute to the pathology and clinical manifestations of BTHS.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Genet Metab Rep Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Genet Metab Rep Year: 2020 Document type: Article